PortfoliosLab logo

Aligos Therapeutics, Inc. (ALGS)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS01626L1052
CUSIP01626L105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.35
Year Range$1.04 - $20.39
EMA (50)$1.52
EMA (200)$7.47
Average Volume$366.53K
Market Capitalization$55.93M

ALGSShare Price Chart


Chart placeholderClick Calculate to get results

ALGSPerformance

The chart shows the growth of $10,000 invested in Aligos Therapeutics, Inc. on Oct 16, 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $900 for a total return of roughly -91.00%. All prices are adjusted for splits and dividends.


ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M8.00%-6.21%
YTD-88.63%-18.17%
6M-88.62%-17.47%
1Y-94.96%-8.89%
5Y-75.94%6.91%
10Y-75.94%6.91%

ALGSMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ALGSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aligos Therapeutics, Inc. Sharpe ratio is -1.00. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSDividend History


Aligos Therapeutics, Inc. doesn't pay dividends

ALGSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSWorst Drawdowns

The table below shows the maximum drawdowns of the Aligos Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aligos Therapeutics, Inc. is 97.02%, recorded on May 6, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.02%Jan 21, 2021327May 6, 2022
-22.62%Nov 17, 202010Dec 1, 20208Dec 11, 202018
-20.62%Dec 24, 20204Dec 30, 20209Jan 13, 202113
-12%Oct 16, 20203Oct 20, 20202Oct 22, 20205
-10.79%Nov 10, 20201Nov 10, 20203Nov 13, 20204
-8.82%Jan 15, 20212Jan 19, 20211Jan 20, 20213
-5.85%Nov 5, 20201Nov 5, 20202Nov 9, 20203
-4.65%Oct 28, 20202Oct 29, 20204Nov 4, 20206
-3.82%Dec 15, 20201Dec 15, 20201Dec 16, 20202
-1.99%Oct 26, 20201Oct 26, 20201Oct 27, 20202

ALGSVolatility Chart

Current Aligos Therapeutics, Inc. volatility is 98.70%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Aligos Therapeutics, Inc.


Loading data...